ES2022454B3 - Sistema terapeutico para la liberacion controlada de drogas. - Google Patents

Sistema terapeutico para la liberacion controlada de drogas.

Info

Publication number
ES2022454B3
ES2022454B3 ES87830223T ES87830223T ES2022454B3 ES 2022454 B3 ES2022454 B3 ES 2022454B3 ES 87830223 T ES87830223 T ES 87830223T ES 87830223 T ES87830223 T ES 87830223T ES 2022454 B3 ES2022454 B3 ES 2022454B3
Authority
ES
Spain
Prior art keywords
drugs
controlled release
therapeutic system
therapeutic
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87830223T
Other languages
English (en)
Inventor
Manna Aldo La
Paolo Colombo
Andrea Gazzaniga
Giancarlo Santus
Ubaldo Conte
Maria Edvige Sangalli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consiglio Nazionale delle Richerche CNR
Recordati Industria Chimica e Farmaceutica SpA
Original Assignee
Consiglio Nazionale delle Richerche CNR
Recordati Industria Chimica e Farmaceutica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT8620803A external-priority patent/IT1213080B/it
Priority claimed from IT8720708A external-priority patent/IT1215527B/it
Application filed by Consiglio Nazionale delle Richerche CNR, Recordati Industria Chimica e Farmaceutica SpA filed Critical Consiglio Nazionale delle Richerche CNR
Application granted granted Critical
Publication of ES2022454B3 publication Critical patent/ES2022454B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
ES87830223T 1986-06-17 1987-06-15 Sistema terapeutico para la liberacion controlada de drogas. Expired - Lifetime ES2022454B3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8620803A IT1213080B (it) 1986-06-17 1986-06-17 Sistemi terapeutico per la cessione controllata di farmaci.
IT8720708A IT1215527B (it) 1987-05-29 1987-05-29 Sistema terapeutico per la cessione controllata di farmaci.

Publications (1)

Publication Number Publication Date
ES2022454B3 true ES2022454B3 (es) 1991-12-01

Family

ID=26327627

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87830223T Expired - Lifetime ES2022454B3 (es) 1986-06-17 1987-06-15 Sistema terapeutico para la liberacion controlada de drogas.

Country Status (3)

Country Link
EP (1) EP0250374B1 (es)
DE (1) DE3769707D1 (es)
ES (1) ES2022454B3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
FI900470A0 (fi) * 1989-01-31 1990-01-30 Int Pharma Agentur Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
EP0386440B1 (de) * 1989-02-11 1992-08-05 Bayer Ag Arzneimittel mit kontrollierter Wirkstoffabgabe
IT1229856B (it) * 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
EP0652745A1 (en) * 1992-07-31 1995-05-17 Daratech Pty. Ltd. Controlled release implants
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
US6156343A (en) * 1994-12-27 2000-12-05 Akzo Nobel N.V. Controlled release preparation
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
KR20000076329A (ko) * 1997-03-25 2000-12-26 다케다 야쿠힌 고교 가부시키가이샤 위장 점막 부착성 약제 조성물
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US20210299053A1 (en) 2018-07-21 2021-09-30 Sushma Paul BERLIA Controlled release formulation comprising flavoxate
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
WO2023089553A1 (en) 2021-11-19 2023-05-25 Berlia Sushma Paul Controlled release formulations of flavoxate and process for preparation thereof
CN114133595B (zh) * 2021-12-06 2023-06-02 广东华美众源生物科技有限公司 一种pH温度双重敏感纳米水凝胶的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
IT1176853B (it) * 1984-10-02 1987-08-18 Eurand Spa Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua

Also Published As

Publication number Publication date
DE3769707D1 (de) 1991-06-06
EP0250374A1 (en) 1987-12-23
EP0250374B1 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
ES2022454B3 (es) Sistema terapeutico para la liberacion controlada de drogas.
BR8702654A (pt) Sistema para administracao pulsatil de drogas
ES540177A0 (es) Sistema cerrado para administracion de medicinas
NO871774D0 (no) Medikament-system med kontrollert frisettelse av det aktive middel.
DE3685094D1 (de) Pharmazeutisches praeparat zur kontrollierten freisetzung von wirkstoffen.
DE3886965T2 (de) Zubereitungen zur gesteuerten Wirkstofffreisetzung.
ES2018781B3 (es) Sistema de cateter para angioplastia.
IT8322832A0 (it) Dispositivo per la somministrazione controllata di farmaci.
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
MX9203816A (es) Sistema de administracion farmaceutica.
IT8521922A0 (it) Sistema di somministrazione di farmaci.
MX7769A (es) Procedimiento para la preparacion de derivados de pirimidina.
BR8807923A (pt) Fechadura de combinacao para sistema de identificacao de sangue
FI875098A0 (fi) Transdermalt terapeutiskt system.
NO865028L (no) Fremgangsmaate for fremstilling av et terapeutisk system.
IT1236706B (it) Sistema sincrofasatore per turbomotore d'aeroplano.
ES2022515B3 (es) Mezclas de sustancias granuladas para la preparacion de soluciones de dialisis. procedimiento para su preparacion. dispositivo para su realizacion.
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
IT1213080B (it) Sistemi terapeutico per la cessione controllata di farmaci.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
MX12003A (es) Procedimiento para la preparacion de composicionesherbicidas.
MX9203154A (es) Sistema terapeutico de liberacion regulada para formulaciones farmaceuticas liquidas.
ES2017454A4 (es) Sistema de distribucion oral controlado de hinchado para drogas
IT8720708A0 (it) Sistema terapeutico per la cessione controllata di farmaci.
ES1004403Y (es) Sistema de seguridad para bidones